Moreover, our results suggest that high serum resistin levels are related to cancer-associated chronic inflammation and support the previous study in which resistin exhibited pro-inflammatory properties by up-regulating the expression of TNF-α and IL-6 and the activation of monocytes [25,26,27,31,32,33]. The gene discussed is RETN; the disease is cancer.